Arrowhead Pharmaceuticals, Inc.

ARWR · Healthcare · Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States

Arrowhead Pharmaceuticals, Inc. (ARWR), in the Healthcare sector, has 20 disclosed filings on Paydirt over the trailing twelve months from 10 corporate insiders: 0 purchases and 20 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 18 and filed Aug 20. The most active filer was Christopher Richard Anzalone with 11 filings.

Add to watchlist

Filings, ttm

0 buys · 20 sells

Traders, ttm

10 insiders

Volume, ttmiDollar value disclosed in the window

$37.3M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Aug 18

Filed Aug 20

ADViAverage daily dollar volume

$181.7M

market data

Share price · 12M

$88.59 (+176.4%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $49.4M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Christopher Richard Anzalone Chief Executive Officer 11 filings JH

James C Hamilton Chief Medical Officer 8 filings MF

Mauro Ferrari Director 2 filings PB

Patrick O'Brien COO and General Counsel 2 filings AO

Adeoye Y Olukotun Director 2 filings MP

Michael S Perry Director 2 filings VV

Victoria Vakiener Director 2 filings DA

Daniel Joseph Apel Chief Financial Officer 1 filing

Recent filings

Adeoye Y OlukotunSALE Director $174K
2,000 sh × $86.96
Exec Aug 18
Filed Aug 20 · 5:25 PM ET Michael S PerrySALE Director $1.0M
11,600 sh × $87.30
Exec Aug 18
Filed Aug 20 · 5:22 PM ET Hongbo LuSALE Director $228K
2,970 sh × $76.88
Exec May 12
Filed May 14 · 5:30 PM ET James C HamiltonSALE Chief Medical Officer $750K
10,000 sh × $75.00
Exec Apr 23
Filed Apr 24 · 5:30 PM ET Daniel Joseph ApelSALE Chief Financial Officer $853K
11,938 sh across 2 lots
Exec Apr 22
Filed Apr 24 · 5:30 PM ET James C HamiltonSALE Chief Medical Officer $642K
10,000 sh × $64.19
Exec Mar 5
Filed Mar 9 · 5:30 PM ET Christopher Richard AnzaloneSALE Chief Executive Officer $872K
13,187 sh across 2 lots
Exec Jan 2
Filed Jan 5 · 5:30 PM ET James C HamiltonSALE Chief Medical Officer $2.4M
38,218 sh across 4 lots
Exec Jan 5
Filed Jan 5 · 5:30 PM ET Patrick O'BrienSALE COO $2.9M
46,734 sh across 7 lots
Exec Jan 5
Filed Jan 5 · 5:30 PM ET Mauro FerrariSALE Director $527K
7,530 sh × $70.00
Exec Dec 26 2025
Filed Dec 30 2025 · 5:30 PM ET Christopher Richard AnzaloneSALE Chief Executive Officer $3.6M
51,726 sh across 2 lots
Exec Dec 29 2025
Filed Dec 30 2025 · 5:30 PM ET Adeoye Y OlukotunSALE Director $620K
9,173 sh across 2 lots
Exec Dec 19 2025
Filed Dec 23 2025 · 5:30 PM ET Christopher Richard AnzaloneSALE Chief Executive Officer $1.7M
24,712 sh across 4 lots
Exec Dec 19 2025
Filed Dec 23 2025 · 5:30 PM ET Victoria VakienerSALE Director $679K
10,040 sh across 3 lots
Exec Dec 19 2025
Filed Dec 23 2025 · 5:30 PM ET William D. WaddillSALE Director $532K
7,867 sh across 2 lots
Exec Dec 19 2025
Filed Dec 23 2025 · 5:30 PM ET Christopher Richard AnzaloneSALE Chief Executive Officer $5.4M
84,018 sh across 3 lots
Exec Dec 17 2025
Filed Dec 19 2025 · 5:30 PM ET Christopher Richard AnzaloneSALE Chief Executive Officer $12.2M
181,832 sh across 9 lots
Exec Dec 15 2025
Filed Dec 16 2025 · 5:30 PM ET Michael S PerrySALE Director $992K
16,250 sh × $61.03
Exec Dec 5 2025
Filed Dec 9 2025 · 5:30 PM ET Mauro FerrariSALE Director $493K
8,750 sh × $56.39
Exec Nov 28 2025
Filed Dec 1 2025 · 5:30 PM ET James C HamiltonSALE Chief Medical Officer $700K
20,000 sh × $35.00
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET James C HamiltonSALE Chief Medical Officer $450K
15,000 sh × $30.00
Exec Sep 12 2025
Filed Sep 16 2025 · 5:30 PM ET James C HamiltonSALE Chief Medical Officer $375K
15,000 sh × $25.00
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET James C HamiltonSALE Chief Medical Officer $188K
9,389 sh × $20.00
Exec Aug 15 2025
Filed Aug 15 2025 · 5:30 PM ET Christopher Richard AnzaloneSALE Chief Executive Officer $1.5M
136,105 sh across 3 lots
Exec Apr 9 2025
Filed Apr 11 2025 · 5:30 PM ET Christopher Richard AnzaloneSALE Chief Executive Officer $775K
51,425 sh × $15.07
Exec Mar 13 2025
Filed Mar 17 2025 · 5:30 PM ET